mdlinx mdlinx
Gastroenterology Articles on MDLinx Top Read Articles
of 2012

Is Moderate Red Wine Consumption Safe in Inactive Inflammatory Bowel Disease Digestion, 08/26/2011

Swanson GR et al. – One week of moderate consumption of red wine in inactive Inflammatory Bowel Disease(IBD) was associated with a significant decrease in stool calprotectin and a significant increase in intestinal permeability. This data suggests that patients with inactive IBD who drink red wine daily may be at an increased long–term risk for disease relapse.

Methods
  • To assess the effects of moderate daily alcohol consumption on intestinal permeability and inflammation, the authors recruited 21 patients: 8 with inactive ulcerative colitis (UC), 6 with inactive Crohn’s disease (CD), and 7 healthy controls.
  • All participants with IBD completed a validated questionnaire on disease activity (Crohn’s disease activity index or ulcerative colitis clinical activity index), to confirm they had inactive disease.
  • All subjects then underwent a baseline assessment that included a blood draw, urine collection after sugar challenge, and stool collection.

Results
  • No subjects flared during the study.
  • Moderate alcohol consumption did not significantly change either clinical disease activity scores or C-reactive protein.
  • In contrast to healthy subjects, daily consumption of red wine significantly (1) decreased stool calprotectin in IBD subjects from baseline (p=0.001) and (2) increased intestinal permeability as measured by urinary lactulose/mannitol excretion (marker of small bowel permeability) in CD (p=0.028) or urinary sucralose secretion (marker of large bowel permeability) in UC (p=0.012).

Read this article on Digestion



Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close